Risk Stratification for Subclinical Pediatric Dyslipidemia
Led By
Dr. Damon Dixon
At the end of this presentation, participants should be able to:
- Explain Pediatric Dyslipidemia Subclinical State
- Apply Lipid Biomarkers for Pediatric Dyslipidemia Management
- Differentiate “Genetic Dyslipidemia” and “Atherogenic Dyslipidemia”
